TET2 and angioimmunoblastic T-cell lymphoma: Numerous studies have shown that most patients with AITL and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) carry TET2 mutations (28, 32, 34–36) and decreased OS of patients (37).